Tuberculosis — United States, 2023
This report describes increases in the prevalence of antibiotic-resistant strains of Neisseria gonorrhoeae in China.
This report describes increases in the prevalence of antibiotic-resistant strains of Neisseria gonorrhoeae in China.
At the 2024 UCSF-UCLA PSMA Conference, Matthew Rettig discusses the critical advancements and challenges in treating metastatic castration-resistant prostate cancer (mCRPC), highlighting the shift towards…
CDC continues to respond to the public health challenge posed by a multistate outbreak of avian influenza A(H5N1) virus, or “A(H5N1) virus” in dairy cows…
APCCC 2024, metastatic castration resistant prostate cancer (mCRPC), PARP Inhibitions, DNA Repair Gene Alterations, ribonucleotide excision genes, TOPARP trial, olaparib, talazoparib, PROfound trial, PROpel trial.
UroToday – GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and…
APCCC 2024, prostate cancer, Metastatic Castration Resistant Prostate Cancer (mCRPC), PARP Inhibitors, BRCA-deficient metastatic prostate cancer, TOPARP-B trial, olaparib, olaparib monotherapy, PROFOUND trial, androgen receptor…
upper tract urothelial carcinoma (UTUC), circulating tumor DNA (ctDNA), circulating tumor DNA in upper tract urothelial carcinoma, Non-organ-confined Upper Tract Urothelial Carcinoma, Muscle-invasive Upper Tract…
APCCC 2024, Advanced Prostate Cancer, Cardiovascular Complications in Advanced Prostate Cancer, androgen deprivation therapy (ADT), Androgen deprivation therapy-related cardiovascular toxicities, RADICAL-PC trial.
The Milestones in Action library aid parents and providers with examples of important developmental milestones for children ages 2 months to 5 years.
Sam Chang engages with Jennifer Linehan to discuss topical chemotherapy for upper tract urothelial carcinoma, particularly utilizing UGN-101 (Jelmyto). Dr. Linehan shares her invaluable insights…
APCCC 2024, PSMA Radioligand Therapy, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), PSMA-617, PSMA-1&T, PSMA-1007 rhPSMA-7, 68Ga PSMA-11, VISION trial, TheraP trial, PSMAfore trial,…